How many acquisitions has Amgen made so far?

Amgen has completed 27 acquisitions so far, with an average acquisition amount of $2.49B.

Which countries does Amgen usually acquire in?

Amgen has made acquisitions in 9 countries with the most activity in United States and Japan.

Which sectors does Amgen target for acquisitions?

Most of Amgen's acquisitions are in Immunotherapy (6) and Oncology (6).

In which year did Amgen make the most acquisitions?

Amgen was most active in 2012, with 5 acquisitions completed in that year.

List of 27 Acquisitions by Amgen (Apr 2026)

Q: Which is Amgen's latest acquisition?

Amgen's most recent acquisition is Dark Blue Therapeutics, a Biotechnology company focused on drugs discovery services, acquired in January 2026.

Amgen has completed 27 acquisitions. Peak acquisition years include 2012 with 5, 2021 with 3, and 2022 with 2. Its acquisition activity has occurred in 9 countries, predominantly in United States (19), with other acquisitions in Japan (1) and United Kingdom (1). Acquisitions have spanned 17 sectors, concentrated primarily in Oncology (6), Immunotherapy (6), and Diversified Pharmaceuticals (5). Over the last five years (2020–2025), the average number of acquisitions per year was 1. The current calendar year has recorded 1 acquisition so far. The most recent acquisition was Dark Blue Therapeutics, a biotechnology company focused on drugs discovery services, founded in 2020 and located in Oxford, which was completed in January 2026.

Here's the year on year acquisition history of Amgen:

Number of Total Acquisitions

Year	# Acquisitions
2026	1
2022	2
2021	3
2020	1
2019	2
2017	2
2015	1
2013	1
2012	5
2011	1
2007	2
2006	1
2005	1
2004	1
2001	1
2000	1
1994	1

View all Acquisitions by Amgen

Recent acquisitions by Amgen

Amgen's most recent acquisition - Dark Blue Therapeutics is a Biotechnology company focused on drugs discovery services, founded in 2020 and located in Oxford. Amgen acquired it in January 2026.

Here is the list of all acquisitions by Amgen sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Jan 06, 2026	Dark Blue Therapeutics	Undisclosed	Bank of America, Goodwin	89	559
Dec 12, 2022	Horizon Therapeutics	Undisclosed	Morgan Stanley, Cooley ... and 7 more	10	182
Aug 04, 2022	ChemoCentryx	Undisclosed	PJT Partners, Goldman Sachs ... and 2 more	81	103
Jul 27, 2021	TeneoBio	$900M	-	29	118
Mar 30, 2021	Rodeo Therapeutics	$55M	Cooley, Gunderson Dettmer	26	436